Amosulalol hydrochloride long acting formulations
US4765988A · kind A · utility
21Cited by
12References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 1987 |
| Grant date | Aug 23, 1988 |
| Priority date | — |
| Expiry date | May 5, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Long acting formulations of amosulalol hydrochloride are provided, wherein the frequency of administering the hypotensive agent is minimized and wherein such formulations are prepared by compounding amosulalol hydrochloride with an enterosoluble material and optionally the inclusion of an organic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.